For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
State Directed Payments redistribute money across states and supercharged growth
Differences in states’ use of SDPs cause an interstate redistribution of taxes as well. Because states are setting different levels of SDPs, spending varies…
Blog
How State Directed Payments turned Medicaid into an interstate transfer scheme
Medicaid’s financing rules have long allowed states to expand spending while shifting much of the cost to federal taxpayers. One of the most important…
Blog
Medicaid financing gimmickry – before and after the One Big Beautiful Bill
Medicaid was created in 1965 as a joint federal-state health insurance program for low-income individuals which targeted families with dependent children, the elderly, and…
Search Posts
New York Post
The Science Shows Eric Adams is Right in Fight to Keep NYC Schools Open
As new cases of the Omicron variant surge, thousands of schools have delayed a return to in-person learning. Cities including Atlanta, Milwaukee, Cleveland and…
City Journal
Omicron’s Silver Lining
New Covid-19 infections are reaching record levels in the U.S. and Europe. The surge is due both to the…
New York Post
New York’s Racial ‘Risk Factor’ for COVID Treatment is Illegal and Immoral
New York City’s and state’s departments of health have reached a divisive and destructive low. In new guidelines rationing scarce, lifesaving oral antiviral medications and…
National Review
Confronting Omicron: One Step Forward, One Step Static
President Joe Biden’s recent address on the Omicron variant was full of holiday miracles. After nearly a year in office, Biden finally conceded…
The Wall Street Journal
Drug Prices Haven’t Been Going Up
Build Back Better may be dead, but its proposed drug price controls will likely reappear: negotiating prices for high-cost drugs in Medicare and price…
City Journal
Testing Our Patience
It has only been around a little more than a month, but the Omicron variant of the SARS-CoV-2 virus that causes Covid-19 has taken…
